ogivrihcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /sitecore Disallow: /Sitecore Disallow: /-/media/OgivriHcpCom/pdf/OgivriColoradoWACSheet Noindex: | ||
Meta Tags
| Title | OGIVRI® (trastuzumab-dkst) – FDA approved Viatris |
| Description | The official HCP website of OGIVRI® (trastuzumab-dkst) Injection. Please see Full Prescribing Information including Boxed |
| Keywords | ogivri, trastuzumab, mylan biosimilars, trastuzumab biosimilar, herceptin biosimilar, herceptin treatment, metastatic breast cancer prognosis, Metastatic breast cancer, Metastatic gastric cancer |
Server Information
| WebSite | |
| Host IP | 3.211.171.92 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
ogivrihcp.com Valuation
|
US$4,282,635
Last updated: 2023-05-19 07:47:18
ogivrihcp.com has Semrush global rank of 2,471,447. ogivrihcp.com has an estimated worth of US$ 4,282,635, based on its estimated Ads revenue. ogivrihcp.com receives approximately 494,151 unique visitors each day. Its web server is located in United States, with IP address 3.211.171.92. According to SiteAdvisor, ogivrihcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,282,635 |
| Daily Ads Revenue | US$3,954 |
| Monthly Ads Revenue | US$118,597 |
| Yearly Ads Revenue | US$1,423,153 |
| Daily Unique Visitors | 32,944 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| ogivrihcp.com. | A | 60 | IP: 3.211.171.92 |
| ogivrihcp.com. | A | 60 | IP: 35.169.232.148 |
| ogivrihcp.com. | A | 60 | IP: 52.2.186.61 |
| ogivrihcp.com. | NS | 86400 | NS Record: ns-1878.awsdns-42.co.uk. |
| ogivrihcp.com. | NS | 86400 | NS Record: ns-488.awsdns-61.com. |
| ogivrihcp.com. | NS | 86400 | NS Record: ns-975.awsdns-57.net. |
| ogivrihcp.com. | NS | 86400 | NS Record: ns-1476.awsdns-56.org. |
HtmlToTextCheckTime:2023-05-19 07:47:18
| X Effective November 29, 2022, Viatris completed the sale of substantially all of its biosimilars portfolio (including related product trademarks) to Biocon Biologics Limited and its subsidiaries (“Biocon”) and the relevant marketing authorizations are in process of being transferred. Viatris Inc. and its subsidiaries (“Viatris”) are not affiliates of Biocon but are providing certain transition services to Biocon following the transaction completion date, such as operating websites (including this site) relating to the biosimilars portfolio on Biocon’s behalf. About About OGIVRI ® About Biosimilars Product Highlights Efficacy and Safety Efficacy Safety How Supplied Patient Support Educational Videos Patient Site Full Prescribing Information including Boxed WARNING Visit Viatris Biosimilars REGISTER For US Healthcare Professionals Only About About OGIVRI ® About Biosimilars Product Highlights Efficacy and Safety Efficacy Safety How Supplied Patient Support Educational Videos The first |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Wed, 14 Sep 2022 08:57:51 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 149 Connection: keep-alive Set-Cookie: AWSALB=L4UvKWaRg4q+3RiuxLfneXzId1S2W2seOmuTTxHekwuh77z1ZaXHN7Fa097ujIywBMK/gWgwPT7Q0mYQqySnRNqZnB7TVOLr7C8N0AcdCnbjBcKgix6hoiDL5eEK; Expires=Wed, 21 Sep 2022 08:57:51 GMT; Path=/ Set-Cookie: AWSALBCORS=L4UvKWaRg4q+3RiuxLfneXzId1S2W2seOmuTTxHekwuh77z1ZaXHN7Fa097ujIywBMK/gWgwPT7Q0mYQqySnRNqZnB7TVOLr7C8N0AcdCnbjBcKgix6hoiDL5eEK; Expires=Wed, 21 Sep 2022 08:57:51 GMT; Path=/; SameSite=None Location: https://www.ogivrihcp.com/ Server: X-Powered-By: X-Responding-Host: RESPONSE_X-POWERED-BY: .* RESPONSE_X-ASPNET-VERSION: .* RESPONSE_SERVER: .* SameSiteCookie: ^(.*)SC_ANALYTICS_GLOBAL\S*|SC_ANALYTICS_SESSION\S*|ASP.NET_SessionId X-Server: i-066f2610f83f75056 X-ASPNET-VERSION: HTTP/2 200 date: Wed, 14 Sep 2022 08:57:52 GMT content-type: text/html; charset=utf-8 content-length: 41011 set-cookie: AWSALB=BsKeP1QPRapJFNyXRB7Ny0vx77VP73WDJdTaVw5kGKhfaVZ1BC6WIZZRUYTK7fofTizsGGZ2uVGjZi2cb2daVo1Nq+x2T12b/KRWlDPQYbxd/j2Q+/FWc8Lg/MJt; Expires=Wed, 21 Sep 2022 08:57:51 GMT; Path=/ set-cookie: AWSALBCORS=BsKeP1QPRapJFNyXRB7Ny0vx77VP73WDJdTaVw5kGKhfaVZ1BC6WIZZRUYTK7fofTizsGGZ2uVGjZi2cb2daVo1Nq+x2T12b/KRWlDPQYbxd/j2Q+/FWc8Lg/MJt; Expires=Wed, 21 Sep 2022 08:57:51 GMT; Path=/; SameSite=None; Secure cache-control: private server: set-cookie: ASP.NET_SessionId=woxzw5dwk2d2fcu1xtsyum23; path=/; HttpOnly;Secure;SameSite=None x-aspnetmvc-version: 5.1 x-aspnet-version: set-cookie: ADRUM_BTa=R:0|g:6cb54696-8109-4363-8dea-5f02bca6758f|n:Mylan-prod_073aad5d-ae3c-4c35-9325-2bb690e7c6d8; expires=Wed, 14-Sep-2022 08:58:22 GMT; path=/ set-cookie: ADRUM_BT1=R:0|i:426683|e:12; expires=Wed, 14-Sep-2022 08:58:22 GMT; path=/ x-powered-by: x-responding-host: response_x-powered-by: .* response_x-aspnet-version: .* response_server: .* samesitecookie: ^(.*)SC_ANALYTICS_GLOBAL\S*|SC_ANALYTICS_SESSION\S*|ASP.NET_SessionId x-server: i-0c73e1ab02cee07c3 |
ogivrihcp.com Whois Information
Domain Name: OGIVRIHCP.COM Registry Domain ID: 2415490875_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-06-21T09:25:22Z Creation Date: 2019-07-22T14:39:39Z Registry Expiry Date: 2023-07-22T14:39:39Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2086851750 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1476.AWSDNS-56.ORG Name Server: NS-1878.AWSDNS-42.CO.UK Name Server: NS-488.AWSDNS-61.COM Name Server: NS-975.AWSDNS-57.NET DNSSEC: unsigned >>> Last update of whois database: 2022-09-14T09:00:41Z <<< |